FeesSafety
Pluang+

SKF Vertevo launches new brand ahead of its December 1 stock market debut

Company Fundamentals
03 Nov 2026, 11:33 WIB
PRNewsWire
View Source
Bullish
SKF Vertevo launches new brand ahead of its December 1 stock market debut

SKF Vertevo, the separated automotive business from SKF, has unveiled its new brand and digital presence as it prepares for its planned stock market listing on December 1, 2026. The new brand reflects the company's racing heritage and commitment to innovation in mobility, signaling its identity as an independent automotive company. This rebranding is a key step in building awareness and engaging stakeholders ahead of the public offering. SKF Vertevo aims to accelerate its growth and future in the automotive sector with this fresh identity.

SKF Vertevo's upcoming stock market listing is set for December 1, 2026. For readers following Industrials-sector stocks, here is Pluang's market snapshot as of Nov 03, 2026 16:11 WIB: Out of 135 priced US Industrials stocks, 67 rose and 56 fell today. Notable movers include Bloom Energy (BE) at USD 205.69 with a 1-day change of +4.81% and Pluang order activity of 22% Sell / 78% Buy, TORM plc (TRMD) at USD 40.88 with a 1-day change of +2.66% and 0% Sell / 100% Buy order activity, and Canadian National Railway Co. (CNI) at USD 123.84 with a 1-day change of -2.32% and 84% Sell / 16% Buy order activity.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
45 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
45 minutes ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
45 minutes ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
1 hour ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App